• Heartbeam Inc BEAT.OQ reported a quarterly adjusted loss of 18 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -15 cents. The lone analyst forecast for the quarter was for a loss of 19 cents per share.

• Reported revenue was zero​; analysts expected zero.

• Heartbeam Inc's reported EPS for the quarter was a loss of 18 cents​.

• The company reported a quarterly loss of $4.91 million.

• Heartbeam Inc shares had fallen by 9.6% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 2.6% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is "hold."

Wall Street's median 12-month price target for Heartbeam Inc is $5.00

This summary was machine generated from LSEG data March 13 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)